Chard (Beta vulgaris L. var. cicla) extract ameliorates hyperglycemia by increasing GLUT2 through Akt2 and antioxidant defense in the liver of rats

Acta Histochemica

Volumn 116, Issue 1, 2014, Pages 32-39

  Gezginci Oktayoglu, Selda ^a   Sacan, Ozlem ^a   Bolkent, Sehnaz ^a   Ipci, Yesim ^b   Kabasakal, Levent ^b   Sener, Goksel ^b   Yanardag, Refiye ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Akt2; Chard extract; GLUT2; Hyperglycemia; Liver; Oxidative stress

Indexed keywords

AKT2 PROTEIN, RAT; ANTIDIABETIC AGENT; ANTIOXIDANT; CATALASE; GLUCOSE TRANSPORTER 2; PEROXIDASE; PLANT EXTRACT; PROTEIN KINASE B; SLC2A2 PROTEIN, RAT; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

ACTIVE TRANSPORT; ANIMAL; BEET; CELL NUCLEUS; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; HYPERGLYCEMIA; LIVER; MALE; METABOLISM; OXIDATIVE STRESS; SPRAGUE DAWLEY RAT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTIOXIDANTS; BETA VULGARIS; CATALASE; CELL NUCLEUS; DIABETES MELLITUS, EXPERIMENTAL; DRUG EVALUATION, PRECLINICAL; GLUCOSE TRANSPORTER TYPE 2; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; LIVER; MALE; OXIDATIVE STRESS; PEROXIDASE; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-AKT; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

EID: 84894903177     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2013.04.016     Document Type: Article

References (39)

1. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
2. Al-Aubaidy H., Jelinek H. Oxidative DNA damage and obesity in type 2 diabetes mellitus. Eur J Endocrinol 2011, 164:899-904.
3. Bell G.I., Kayano T., Buse J.B., Burant C.F., Takeda J., Lin D., et al. Molecular biology of mammalian glucose transporters. Diabetes Care 1990, 13:198-208.
4. Beutler E. Glutathione in red cell metabolism. A mannual of biochemical methods 1975, Grune and Stratton, New York.
5. Buteau J., Shlien A., Foisy S., Accili D. Metabolic diapause in pancreatic beta-cells expressing a gain-of-function mutant of the forkhead protein Foxo1. J Biol Chem 2007, 282:287-293.
6. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979, 59:527-605.
7. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B., et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001, 292:1728-1731.
8. Chong Z.Z., Kang J.Q., Maiese K. Akt1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-x(L) and caspase 1, 3, and 9. Exp Cell Res 2004, 296:196-207.
9. Dandona P., Thusu K., Cook S., Snyder B., Makowski J., Armstrong D., et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996, 347:444-445.
10. Dijoux M.G., Lavaud C., Massiot G., Le Men-Olivier L. Flavonoids from Beta vulgaris varieties. Fitoterapia 1995, LXVI:189.
11. Faurschou M., Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003, 5:1317-1327.
12. Gezginci-Oktayoglu S., Sacan O., Yanardag R., Karatug A., Bolkent S. Exendin-4 improves hepatocyte injury by decreasing proliferation through blocking NGF/TrkA in diabetic mice. Peptides 2011, 32:223-231.
13. Gupta S., Kataria M., Gupta P.K., Murganandan S., Yashroy R.C. Protective role of extracts of neem seeds in diabetes caused by streptozotocin in rats. J Ethnopharmacol 2004, 90:185-189.
14. Karker H. Method for estimation of serum adenosine deaminase. Scand J Clin Lab Invest 1964, 16:570-574.
15. Kettle A.J., Winterbourn C.C. Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Rep 1997, 3:12-18.
16. Kohn A.D., Summers S.A., Birnbaum M.J., Roth R.A. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 1996, 271:31372-31378.
17. Koyuturk M., Yanardag R., Bolkent S., Tunali S. The potential role of combined anti-oxidants against cadmium toxicity on liver of rats. Toxicol Ind Health 2007, 23:393-401.
18. Kupriyanova T.A., Kandror K.V. Akt-2 binds to Glut4-containing vesicles and phosphorylates their component proteins in response to insulin. J Biol Chem 1999, 274:1458-1464.
19. Kwon O., Eck P., Chen S., Corpe C.P., Lee J.H., Kruhlak M., et al. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J 2007, 21:366-377.
20. Hoshino T., Yamada K., Masouka K., Tsuboi I., Itoh K., Nonaka K., et al. Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract 1994, 25:97-102.
21. Ledwozyw A., Michalak J., Stepien A., Kadziolka A. The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 1986, 155:275-283.
22. Lee D.M., Hoffman W.H., Carl G.F., Khichi M., Cornwell P.E. Lipid peroxidation and antioxidant vitamins prior to, during, and after correction of diabetic ketoacidosis. J Diabetes Complications 2002, 16:294-300.
23. Lee S.J., Zhang G.F., Sung N.J. Hypolipidemic and hypoglycemic effects of Orostachys japonicus A. Berger extracts in streptozotocin-induced diabetic rats. Nutr Res Pract 2011, 5:301-307.
24. Liao J., Barthel A., Nakatani K., Roth R.A. Activation of protein kinase B/Akt is sufficient to repress the glucocorticoid and cAMP induction of phosphoenolpyruvate carboxykinase gene. J Biol Chem 1998, 273:27320-27324.
25. Lo S., Russell J.C., Taylor A.W. Determination of glycogen in small tissue samples. J Appl Physiol 1970, 28:234-236.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
27. Maiti R., Jana D., Das U.K., Ghosh D. Antidiabetic effects of aqueous extract of seed of Tamarindus indica in streptozotocin-induced diabetic rats. J Ethnopharmacol 2004, 92:85-91.
28. Masayuki Y., Shoichi H. Extraction of blood glucose sugar lowering saponins from Beta vulgaris (Jpn Kokaia Tokkyo Koho JP 0 9 25290 Appl. 95/177.220, Japan). Chem Abstr 1997, 126203699 c.
29. Matsui T., Ogunwande I.A., Abesundara K.J., Matsumoto K. Anti-hyperglycemic potential of natural products. Mini Rev Med Chem 2006, 6:349-356.
30. Morino K., Petersen K.F., Shulman G.I. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006, 2:S9-S15.
31. Mylroie A.A., Collins H., Umbles C., Kyle J. Erythrocyte superoxide dismutase activity and other parameters of copper status in rats ingesting lead acetate. Toxicol Appl Pharmacol 1986, 82:512-520.
32. Reaven G.M. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995, 75:473-486.
33. Robertson R.P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004, 279:42351-42354.
34. Stumwoll M., Goldstein B.J., van Haeften T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365:1333-1346.
35. Thorens B., Charron M.J., Lodish H.F. Molecular physiology of glucose transporters. Diabetes Care 1990, 13:209-218.
36. Ueki K., Yamamoto-Honda R., Kaburagi Y., Yamauchi T., Tobe K., Burgering B.M., et al. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem 1998, 273:5315-5322.
37. Usami S., Hjelle O.P., Ottersen O.P. Differential cellular distribution of glutathione - an endogenous antioxidant in the guinea pig inner ear. Brain Res 1996, 743:337-340.
38. Wei H., Frenkel K. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoter. Carcinogenesis 1993, 14:1195-1201.
39. Welihinda J., Karuanayake E.H. Extra-pancreatic effect of Momordica charantia in rats. J Ethnopharmacol 1986, 17:247-255.